Cell- and Tissue-Based Proteome Profiling and Bioimaging with Probes Derived from a Potent AXL Kinase Inhibitor

Binbin Zheng1, Haijun Guo1, Nan Ma1

  • 1School of Pharmacy, Jinan University, Guangzhou City Key Laboratory of Precision Chemical Drug Development, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, Ministry of Education (MOE) of People's Republic of China, 601 Huangpu Avenue West, Guangzhou, 510632, China.

Insights

Researchers identified new targets for the cancer drug AXL, including BCAP31 and LPCAT3. They also developed imaging probes to detect AXL binding in cells and tissues, aiding cancer research.

Area of Science:

  • Oncology
  • Biochemistry
  • Chemical Biology

Background:

  • AXL receptor tyrosine kinase is a novel target for cancer therapeutics.
  • Limited availability of potent and selective AXL inhibitors hinders therapeutic development.
  • Our group previously developed a lead compound, 9im, with potent and specific AXL inhibition.

Purpose of the Study:

  • To identify novel cellular targets of the AXL inhibitor 9im.
  • To develop imaging probes for visualizing 9im-target interactions in live systems.
  • To validate 9im as a tool for detecting AXL in biological contexts.

Main Methods:

  • Competitive affinity-based proteome profiling was employed to discover 9im's cellular targets.
  • Development of trans-cyclooctene (TCO) and acedan-containing probes for imaging.
  • In situ imaging of 9im-protein binding in live cells and tumor tissues.

Main Results:

  • Identification of several previously unknown cellular targets for 9im, including BCAP31, LPCAT3, POR, TM9SF3, SCCPDH, and CANX.
  • Successful development of TCO and acedan probes for visualizing target engagement.
  • Demonstration of probe utility in imaging 9im binding within cellular and tissue environments.

Conclusions:

  • The AXL inhibitor 9im engages multiple novel cellular targets beyond AXL.
  • Developed imaging probes are effective tools for studying drug-target interactions in complex biological systems.
  • These findings provide a foundation for advancing AXL-targeted cancer therapies and diagnostic tools.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
551
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.8K
Base Quantities and Derived Quantities01:14

Base Quantities and Derived Quantities

In any system of units, the units for some physical quantities must be specified through a measurement process. These measurements are the base quantities of the system, and their units are the base units of the system. The algebraic combinations of the base values can then be used to express all other physical quantities. Each of these physical quantities is then referred to as a derived quantity, with each unit being referred to as a derived unit.
The International Organization for...
26.4K